Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 519

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001

Open access
Acquadro, Catherine, Berzon, Rick, Dubois, Dominique, Leidy, Nancy Kline, Marquis, Patrick, Revicki, Dennis, Rothman, Margaret·2003·Value in Health

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1524-4733.2003.65309.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 34

  1. Bergner, 1989, Quality of life, health status, and clinical research, Med Care, 27, S148, 10.1097/00005650-198903001-00012 · DOI · Paper page
  2. Leidy, 1999, Recommendations for evaluating the validity of quality of life claims for labeling and promotion, Value Health, 2, 113, 10.1046/j.1524-4733.1999.02210.x · DOI · Paper page
  3. Revicki, 2000, Recommendations on health-related quality of life research to support labeling and promotional claims in the United States, Qual Life Res, 9, 887, 10.1023/A:1008996223999 · DOI · Paper page
  4. Santanello, 2002, Regulatory issues for health-related quality of life—PhRMA Health Outcomes Committee Workshop, 1999, Value Health, 5, 14, 10.1046/j.1524-4733.2002.51047.x · DOI
  5. Chassany, 2002, Patient-reported outcomes: the example of health-related quality of life—A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process, DIA J, 36, 209
  6. Rothman, 1993, Effects of adult day health care on health outcomes and satisfaction with care, Med Care, 31, 38
  7. Rothman, 2001, Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials, Dig Dis Sci, 46, 1540, 10.1023/A:1010660425522 · DOI
  8. Portenoy, 1994, The memorial symptom assessment scale. an instrument for the evaluation of symptom prevalence, characteristics and distress, Eur J Cancer, 30A, 1326, 10.1016/0959-8049(94)90182-1 · DOI · Paper page
  9. American Thoracic Society, 1995, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 152, S77
  10. Eltayara, 1996, Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 154, 1726, 10.1164/ajrccm.154.6.8970362 · DOI · Paper page
  11. O-Donnell, 2000, Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?, Chest, 117, S42, 10.1378/chest.117.2_suppl.42S · DOI · Paper page
  12. Bostrom, 2000, Shoulder rotational strength, movement, pain and joint tenderness as indicators of upper-extremity activity limitation in moderate rheumatoid arthritis, Scand J Rehab Med, 32, 134, 10.1080/003655000750045488 · doi:10.1080/003655000750045488
  13. Lee, 2001, Self-reports and clinician-measured physical function among patients with low back pain: a comparison, Arch Phys Med Rehabil, 82, 227, 10.1053/apmr.2001.18214 · DOI
  14. Kaliner, 1997, Allergy care in the next millennium: guidelines for the specialty. Presidential Address, J Allergy Clin Immunol, 99, 729, 10.1016/S0091-6749(97)80003-6 · DOI
  15. 1999, An evidence-based appraisal of reflux disease management—Genval Workshop Report, Gut, 44, S1
  16. Boers, 1998, The OMERACT filter for outcome measures in rheumatology, J Rheumatol, 25, 198
  17. Strand, 2000, Endpoints: consensus recommendations from OMERACT IV, Lupus, 9, 322, 10.1191/096120300678828424 · DOI
  18. Cramer, 2000, The effect of levetiracetam on epilepsy-related quality of life, Epilepsia, 41, 868, 10.1111/j.1528-1157.2000.tb00255.x · DOI
  19. Santanello, 1997, Improvement in migraine-specific quality of life in a clinical trial of rizatriptan, Cephalalgia, 17, 867, 10.1046/j.1468-2982.1997.1708867.x · doi:10.1046/j.1468-2982.1997.1708867.x
  20. Group for the Respect of Ethics and Excellence in Science (GREES) Rheumatoid Arthritis Section, 1998, Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis, Br J Rheumatol, 37, 211, 10.1093/rheumatology/37.2.211 · DOI
  21. Johnson, 1985, Food and Drug Administration requirements for approval of new anticancer drugs, Cancer Treat Rep, 69, 155
  22. Lohr, 1996, Evaluating quality-of-life and health status instruments: development of scientific review criteria, Clin Ther, 18, 979, 10.1016/S0149-2918(96)80054-3 · DOI · Paper page
  23. Likert, 1932, A technique for the measurement of attitudes, Arch Psychol, 140, 1
  24. Fayers, 1997, Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the UK medical research council experience, Eur J Cancer, 33, 20, 10.1016/S0959-8049(96)00412-1 · DOI · Paper page
  25. Machin, 1998, Suggestions for presentation of quality of life data from clinical trials, Stat Med, 17, 711, 10.1002/(SICI)1097-0258(19980315/15)17:5/7<711::AID-SIM816>3.0.CO;2-H · doi:10.1002/(sici)1097-0258(19980315/15)17:5/7<711::aid-sim816>3.0.co;2-h
  26. Sanders, 1998, Reporting on quality of life in randomised controlled trials: bibliographic study, Br Med J, 317, 1191, 10.1136/bmj.317.7167.1191 · DOI · Paper page
  27. 1994, Prevalence of disability and associated health conditions—United States, 1991–1992, Morb Mortal Wkly Rep, 43, 730
  28. Segal, 1998, The importance of patient empowerment in health system reform, Health Policy, 44, 31, 10.1016/S0168-8510(98)00007-4 · DOI
  29. Eysenbach, 2001, The role of e-health and consumer health informatics for evidence-based patient choice in the 21st century, Clin Dermatol, 19, 11, 10.1016/S0738-081X(00)00202-9 · DOI
  30. Ball, 2001, E-health: transforming the physician/patient relationship, Int J Med Inf, 61, 1, 10.1016/S1386-5056(00)00130-1 · DOI · Paper page
  31. Coile, 2000, The digital transformation of health care, Physician Exec, 26, 8
  32. Coile, 2000, E-health: reinventing healthcare in the information age, J Healthc Manag, 45, 206, 10.1097/00115514-200005000-00011 · DOI
  33. Kiebert, 1991, The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review, J Clin Oncol, 9, 1059, 10.1200/JCO.1991.9.6.1059 · DOI · Paper page
  34. Arunkumar, 2000, Parent- and patient-validated content of pediatric epilepsy quality-of-life assessment, Epilepsia, 41, 1474, 10.1111/j.1528-1157.2000.tb00125.x · DOI

Cited by

See all 519

Metadata

Authors
Acquadro, C., Berzon, R., Dubois, D., Leidy, N. K., Marquis, P., Revicki, D., & Rothman, M.
Venue
Value in Health
Publisher
Elsevier BV
Published
2003-09
Volume
6
Issue
5
Pages
522-531
ISSN
1098-3015 (ISSN-L)
OpenAlex
W2094101973
Cited by
519
References
3
FWCI
31.02
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001. https://app.cochat.ai/papers/10.1046/j.1524-4733.2003.65309.x
The paper
Acquadro, C., Berzon, R., Dubois, D., Leidy, N. K., Marquis, P., Revicki, D., & Rothman, M. (2003). Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001. Value in Health. https://doi.org/10.1046/j.1524-4733.2003.65309.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.